Cryptococcus neoformans growth and protection from innate immunity are dependent on expression of a virulence-associated DEAD-Box protein, Vad1

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 777-788

  Qiu, Jin ^a   Olszewski, Michal A ^b,c   Williamson, Peter R ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; FUNGAL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE ASSOCIATED DEAD BOX PROTEIN; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FUNGUS GROWTH; FUNGUS MUTANT; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; BRAIN; CELL LINE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION, FUNGAL; IMMUNITY, INNATE; LEUKOCYTES; LUNG; LUNG DISEASES, FUNGAL; MICE; PHAGOCYTOSIS; SPLEEN; VIRULENCE;

EID: 84874733039     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00821-12     Document Type: Article

References (47)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
2. Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the U.S.: 1997-2009. PlosOne, in press.
3. Li SS, Mody CH. 2010. Cryptococcus. Proc. Am. Thorac. Soc. 7:186-196.
4. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
5. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. 2009. Accumulation of CD11bΔ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J. Immunol. 183:8044-8053.
6. Osterholzer JJ, Chen GH, Olszewski MA, Zhang YM, Curtis JL, Huffnagle GB, Toews GB. 2011. Chemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection. Am. J. Pathol. 178:198-211.
7. Osterholzer JJ, Milam JE, Chen GH, Toews GB, Huffnagle GB, Olszewski MA. 2009. Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect. Immun. 77:3749-3758.
8. Osterholzer JJ, Surana R, Milam JE, Montano GT, Chen GH, Sonstein J, Curtis JL, Huffnagle GB, Toews GB, Olszewski MA. 2009. Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am. J. Pathol. 174:932-943.
9. Qiu Y, Davis MJ, Dayrit JK, Hadd Z, Meister DL, Osterholzer JJ, Williamson PR, Olszewski MA. 2012. Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination of virulent Cryptococcus neoformans in mice. PLoS One 7(10):e47853. doi:10.1371/journal.pone.0047853.
10. Zhu X, Williamson PR. 2004. Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res. 5:1-10.
11. Chen GH, McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA. 2008. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect. Immun. 76:2379-2391.
12. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. 1994. The role of CD4Δ and CD8Δ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol. 55:35-42.
13. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen GH, Erb-Downward J, Osterholzer JJ, Toews GB, Huffnagle GB, Olszewski MA. 2009. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect. Immun. 77:5389-5399.
14. Kawakami K, Koguchi Y, Qureshi MH, Yara S, Kinjo Y, Miyazato A, Nishizawa A, Nariuchi H, Saito A. 2000. Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice. Microbiol. Immunol. 44:1033-1041.
15. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2021-2027.
16. Voelz K, Lammas DA, May RC. 2009. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect. Immun. 77:3450-3457.
17. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. 2011. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One 6:e17204. doi:10.1371/journal.pone.0017204.
18. Zhang Y, Wang F, Bhan U, Huffnagle GB, Toews GB, Standiford TJ, Olszewski MA. 2010. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am. J. Pathol. 177:754-765.
19. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. 2009. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175:2489-2500.
20. Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB, Huffnagle GB. 2011. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect. Immun. 79:1915-1926.
21. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R, III, Huffnagle GB, Toews GB. 2007. Role of granulocyte macrophage colonystimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am. J. Pathol. 170:1028-1040.
22. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174: 1027-1036.
23. Huffnagle GB, Traynor TR, McDonald RA, Olszewski MA, Lindell DM, Herring AC, Toews GB. 2000. Leukocyte recruitment during pulmonary Cryptococcus neoformans infection. Immunopharmacology 48:231-236.
24. Alanio A, Desnos-Ollivier M, Dromer F. 2011. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. mBio 2(4):e00158-11. doi:10.1128/mBio.00158-11.
25. Mansour MK, Vyas JM, Levitz SM. 2011. Dynamic virulence: real-time assessment of intracellular pathogenesis links Cryptococcus neoformans phenotype with clinical outcome. mBio 2(5):e00217-11. doi:10.1128/mBio.00217-11.
26. Noverr MC, Cox GM, Perfect JR, Huffnagle GB. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:1538-1547.
27. Noverr MC, Williamson PR, Fajardo RS, Huffnagle GB. 2004. CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect. Immun. 72:1693-1699.
28. Olszewski M, Noverr M, Chen G, Toews G, Cox G, Perfect J, Huffnagle G. 2004. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am. J. Pathol. 164:1761-1771.
29. Olszewski MA, Zhang Y, Huffnagle GB. 2010. Mechanisms of cryptococcal virulence and persistence. Future Microbiol. 5:1269-1288.
30. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, Kubes P, Mody CH. 2010. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J. Clin. Invest. 120:1683-1693.
31. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsuledeficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
32. Valdez PA, Vithayathil PJ, Janelsins BM, Shaffer AL, Williamson PR, Datta SK. 2012. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36:668-679.
33. Blackstock R, Buchanan KL, Cherniak R, Mitchell TG, Wong B, Bartiss A, Jackson L, Murphy JW. 1999. Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia 147:1-11.
34. Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths EJ, Geddes JM, Hu G, Jung WH, Kretschmer M, Saikia S, Wang J. 2011. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 9:193-203.
35. Liu X, Hu G, Panepinto J, Williamson P. 2006. Role of a VPS41 homolog in starvation response and virulence of Cryptococcus neoformans. Mol. Microbiol. 61:1132-1146.
36. Panepinto J, Liu L, Ramos J, Zhu X, Valyi-Nagy T, Eksi S, Fu J, Jaffe H, Wickes B, Williamson P. 2005. The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans. J. Clin. Invest. 115:632-641.
37. Wormley FL, Jr, Perfect JR. 2005. Immunology of infection caused by Cryptococcus neoformans. Methods Mol. Med. 118:193-198.
38. -T cells are key regulators of the severity of reactivation histoplasmosis. J. Immunol. 177: 1763-1771.
39. Liu L, Tewari RP, Williamson PR. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
40. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL, Jr. 2010. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176:774-785.
41. Panepinto J, Williamson P. 2006. Intersection of fungal fitness and virulence in Cryptococcus neoformans. FEMS Yeast Res. 6:489-498.
42. Wormley FL, Jr, Cox GM, Perfect JR. 2005. Evaluation of host immune responses to pulmonary cryptococcosis using a temperaturesensitive C. neoformans calcineurin A mutant strain. Microb. Pathog. 38:113-123.
43. He X, Lyons DM, Toffaletti DL, Wang F, Qiu Y, Davis MJ, Meister DL, Dayrit JK, Lee A, Osterholzer JJ, Perfect JR, Olszewski MA. 2012. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am. J. Pathol. 181:1356-1366.
44. Guillot L, Carroll SF, Homer R, Qureshi ST. 2008. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection. Infect. Immun. 76: 4745-4756.
45. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB. 2002. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70:2959-2964.
46. Vecchiarelli A, Retini C, Pietrella D, Monari C, Tascini C, Beccari T, Kozel TR. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect. Immun. 63:2919-2923.
47. Vujanovic NL. 2011. Role of TNF superfamily ligands in innate immunity. Immunol. Res. 50:159-174.